Results of treatment and survival of 231 patients with stage III bronchogenic carcinoma

ABSTRACT

Two hundred and thirty one patients with stage III Bronchogenic Carcinoma had been studied at NEMROCK [1974 1985]. 82% of patients had non small cell lung cancer, while 18% of patients had small cell lung cancer. 29% of patients received radiation therapy alone and 30% of patients received chemotherapy, while 41% of patients received combination of chemo and radiotherapy complete remission after treatment was obtained in 19.5% of patients, all of them received combined modality of treatment with a mean duration of response 10.5 +/- 11 months. There was a better 18 months survival for the patients received combined treatment modality as compared with other groups, and the difference was significant P < 0. 05]